- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04697823
Effect of Hyaluronan-enriched Medium on the Cumulative Ongoing Pregnancy Rate. (TETHER)
May 23, 2023 updated by: Sophie Debrock, KU Leuven
Effect of Hyaluronan-enriched Medium on the Cumulative Ongoing Pregnancy Rate: a Prospective Randomized Trial
Assessing whether the use of hyaluronan-enriched transfer medium can increase the cumulative ongoing pregnancy rate
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
400
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sophie Debrock, PhD
- Phone Number: 0032016340812
- Email: sophie.debrock@uzleuven.be
Study Locations
-
-
-
Leuven, Belgium, 3000
- Recruiting
- Leuven University Fertility Center
-
Contact:
- Sophie Debrock, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Patients with own oocytes/embryos;
- Patients with female age at 1st OR in the study <40 year;
- Patients planned for a 2nd oocyte retrieval, with no clinical ongoing pregnancy after the previous oocyte retrieval
- Patients planned for a 3rd oocyte retrieval with no clinical ongoing pregnancy after previous oocyte retrievals
- Patients with female age at 1st OR in the study <40 year;
- Patients with BMI ≤32;
- Patients with written informed consent;
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: study group
Patients receiving an embryo transfer in hyaluronan-enriched transfer medium
|
In the study group, an embryo transfer will be performed in hyaluronan-enriched transfer medium
|
No Intervention: control group
Patients receiving an embryo transfer in conventional culture medium
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
number of transfers needed to reach ongoing pregnancy
Time Frame: ongoing defined as a pregancy with a viable fetus with FHB at 12 weeks of pregnancy
|
The primary outcome parameter is the number of transfers needed to reach ongoing pregnancy (ongoing defined as a pregancy with a viable fetus with FHB at 12 weeks of pregnancy), as a time-to-event outcome variable.
Patients that do not reach pregnancy, are censored at their last transfer.
|
ongoing defined as a pregancy with a viable fetus with FHB at 12 weeks of pregnancy
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
number of transfers needed to reach clinical pregnancy, life birth, miscarriage, multiple pregnancy
Time Frame: until Live birth: 9 months after ET
|
clinical pregnancy is defined as a pregnancy with at least one intrauterine (IU) or extrauterine (EU) fetal sac at 6-7 weeks of pregnancy)
|
until Live birth: 9 months after ET
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2021
Primary Completion (Anticipated)
January 1, 2024
Study Completion (Anticipated)
December 31, 2024
Study Registration Dates
First Submitted
December 16, 2020
First Submitted That Met QC Criteria
January 5, 2021
First Posted (Actual)
January 6, 2021
Study Record Updates
Last Update Posted (Actual)
May 24, 2023
Last Update Submitted That Met QC Criteria
May 23, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- S64387
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Randomized Controlled Trial
-
Parc de Salut MarRecruitingRandomized Controlled TrialSpain
-
Assistance Publique - Hôpitaux de ParisUniversity of OxfordCompletedRandomized Controlled TrialUnited Kingdom, France
-
Chinese University of Hong KongCompletedRandomized Controlled Trial | OsteotomyHong Kong
-
Universitat Autonoma de BarcelonaMinisterio de Economía y Competitividad, SpainRecruitingRandomized Controlled TrialSpain
-
Fujian Medical University Union HospitalRecruitinga Randomized Controlled TrialChina
-
US Department of Veterans AffairsCompletedSmoking Cessation | Randomized Controlled TrialUnited States
-
Goethe UniversityCompletedRandomized Controlled Trial | Fascia | Myofascial | StretchingGermany
-
Fundacio d'Investigacio en Atencio Primaria Jordi...UnknownRandomized Controlled Trial | Primary Care | Advance DirectivesSpain
-
Universidad de ZaragozaCompletedCognitive Change | Aging | Randomized Controlled Trial | Occupational Therapy
-
Cairo UniversityUnknownRandomized Controlled Trial, Human StudyEgypt
Clinical Trials on use of hyaluronan-enriched transfer medium
-
Aretaieion University HospitalCompletedClinical Pregnancy Rate
-
South Valley UniversityIbn Sina Hospital; Qena Fertility Center, Qena, EgyptUnknownImprovement of Embryo Transfer Technique | Improvement of Implantation
-
A. M. ZeiherEli Lilly and Company; Johann Wolfgang Goethe University Hospital; Guidant Corporation and other collaboratorsCompletedMyocardial InfarctionGermany, Switzerland
-
The Cleveland ClinicCompletedInfraorbital HollowsUnited States
-
University of Colorado, DenverUniversity of RochesterEnrolling by invitationSerum Based Diagnosis of and Monitoring of Infection Recovery in Orthopedic Spine Implant InfectionsSurgical Site Infection | Staphylococcus Aureus Infection | Orthopedic Procedures | SpineUnited States
-
Hospices Civils de LyonRecruiting
-
ART Fertility Clinics LLCNot yet recruitingInfertility | In Vitro Fertilization
-
Voronezh N.N. Burdenko State Medical AcademyCompletedUlcer HemorrhageRussian Federation
-
Uppsala UniversityLund UniversityCompleted
-
University of MinnesotaNational Institute on Drug Abuse (NIDA); National Cancer Institute (NCI)CompletedTobacco Use Disorder | Nicotine DependenceUnited States